monoclonal antibody

Samsung BioLogics To Manufacture Antibody Drug For Bristol-Myers Squibb

Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its Songdo Incheon plant in South Korea.

China’s Zongyi Group Invests In US-Based ContraFect Corporation

The Zongyi Group of China has invested US$8.6 million into US-based ContraFect Corporation as part of a US$9.5 million financing.

X-BODY, Jiangsu Hengrui To Develop Novel Therapeutic Antibodies

X-BODY Biosciences has signed an agreement with Jiangsu Hengrui to commercialize therapeutic antibodies for age-related macular degeneration.

Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine

Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.

Simcere To Begin Clinical Trials On VEGF Inhibitor

Simcere Pharma has received SFDA approval to begin first-in-man trials with its humanized monoclonal antibody candidate, APX003.

A*STAR Scientists Target Intracellular Oncoprotein With Antibodies

A*STAR scientists have used antibodies to target proteins within the cancer cell which were previously thought to be inaccessible.